0179 BIOHLDG
- 0.060
- -0.005-7.69%
BIOHLDG News
Forbid of Direct Business Transaction (DBT) Due to Rule 10.10(3)
BIOHLDG: Quarterly rpt on consolidated results for the financial period ended 30/09/2024 (Amended Announcement)
BIOHLDG: Quarterly rpt on consolidated results for the financial period ended 30/09/2024
BIOHLDG: Quarterly rpt on consolidated results for the financial period ended 30/06/2024
BIOHLDG: Change in Principal Officer - MISS GOH SIOW CHENG
BIOHLDG: Change in Boardroom - MISS GOH SIOW CHENG
BIOHLDG: General Meetings: Outcome of Meeting
BIOHLDG: Quarterly rpt on consolidated results for the financial period ended 31/03/2024
BIOHLDG: Change in Boardroom - DATUK CHONG LOONG MEN
BIOHLDG: Annual Report & CG Report - 2023
BIOHLDG: DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
BIOHLDG: General Meetings: Notice of Meeting
BIOHLDG: Change of Address
BIOHLDG: Quarterly rpt on consolidated results for the financial period ended 31/12/2023
BIOHLDG: DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
BIOHLDG: NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
BIOHLDG: Renounceable rights issue of 526,099,537 warrants ("Warrants B") on the basis of 3 Warrants B for every 8 existing ordinary shares ("BIOHLDG share(s)" or "share(s)") in the Company at the issue price of RM0.035 per Warrant B ("Rights Issue of Warr
BIOHLDG: NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
BIOHLDG: RENOUNCEABLE RIGHTS ISSUE OF UP TO 630,084,138 NEW WARRANTS ("WARRANT(S)") ON THE BASIS OF 3 WARRANTS FOR EVERY 8 EXISTING ORDINARY SHARES ("BIOALPHA SHARE(S)" OR "SHARE(S)") HELD AS AT 5.00 P.M. ON 11 JANUARY 2024 AT AN ISSUE PRICE OF RM0.035 PER
BIOHLDG: NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
No Data